Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Change in Acquisitions & Divestments: 2019-2025

Historic Change in Acquisitions & Divestments for Beam Therapeutics (BEAM) over the last 6 years, with Sep 2025 value amounting to $240.6 million.

  • Beam Therapeutics' Change in Acquisitions & Divestments rose 31.50% to $240.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $753.7 million, marking a year-over-year increase of 6.74%. This contributed to the annual value of $680.4 million for FY2024, which is 37.57% down from last year.
  • According to the latest figures from Q3 2025, Beam Therapeutics' Change in Acquisitions & Divestments is $240.6 million, which was up 44.39% from $166.7 million recorded in Q2 2025.
  • Beam Therapeutics' Change in Acquisitions & Divestments' 5-year high stood at $365.5 million during Q2 2023, with a 5-year trough of $20.4 million in Q1 2021.
  • In the last 3 years, Beam Therapeutics' Change in Acquisitions & Divestments had a median value of $217.1 million in 2025 and averaged $217.7 million.
  • Per our database at Business Quant, Beam Therapeutics' Change in Acquisitions & Divestments spiked by 683.91% in 2022 and then plummeted by 56.97% in 2023.
  • Beam Therapeutics' Change in Acquisitions & Divestments (Quarterly) stood at $106.3 million in 2021, then soared by 238.59% to $360.1 million in 2022, then tumbled by 56.97% to $155.0 million in 2023, then fell by 16.59% to $129.2 million in 2024, then skyrocketed by 31.50% to $240.6 million in 2025.
  • Its Change in Acquisitions & Divestments was $240.6 million in Q3 2025, compared to $166.7 million in Q2 2025 and $217.1 million in Q1 2025.